Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Trading Cabana -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (5457)	5/11/2009 11:06:10 AM
From: Kevin Podsiadlik	Respond to of 6370

The parts of that I found interesting: The closing of the offering is expected to take place on or about May 16, 2009 A Saturday? Who closes a stock offering on a Saturday? Hemispherx Biopharma, Inc. plans to use the net proceeds from the offering to fund commercialization of Alferon N and for other research and development and general corporate purposes. They mention Alferon, the drug so unmarketable they ended up throwing out all their inventory of it for having passed its expiration date, but NOT Ampligen, their "headliner" drug (currently cast as a CFS treatment), which is the one due for review this month.